New Male Infertility Treatment Increasing Healthy Sperm Counts in Men Wanting Children

July 5, 2009 - PRLog -- In the United States nearly 2 million men per year deal with issues related to infertility. Now a leading San Diego fertility doctor has created a male infertility treatment, based on research from over 60 fertility studies, to help men increase healthy sperm counts.

source: (Incidence (annual) of Male infertility: at least 2 million annual cases (based on NWHIC)

When it comes to having children and starting a family a man not only needs a high sperm count but also a healthy sperm count. That is the basis of a new male fertility product called Proceptin, which not only increases sperm counts but more importantly increases "health" sperm counts.

Developed by Dr. Steven A Brody, the use of nutritional supplements and treatments such as Proceptin®, with the proper antioxidants may reduce the adverse effects of oxidative stress on reproductive tissue and organs, and potentially improve sperm function.

Steven A. Brody, M.D., Ph.D. received his Bachelor's degree and Master's degree from Brown University in Providence, RI. He received his medical degree from Washington University School of Medicine in St. Louis. He completed his internship at Yale University School of Medicine in New Haven, Connecticut. In 1986 he completed his OB/GYN Residency at Stanford University Medical Center. After finishing his Fellowship in Reproductive Endocrinology at Baylor College of Medicine, he joined the full-time medical faculty as Associate Director of the Division of Reproductive Endocrinology until 1992.

Dr. Brody is Board Certified in Obstetrics & Gynecology, Internal Medicine, Endocrinology & Medicine, and the subspecialty of Reproductive Endocrinology & Infertility. He has received special Certification in Operative Laparoscopy and Operative Hysteroscopy. As an internationally-recognized specialist and lecturer in reproductive endocrinology and infertility, his main interests include: in vitro fertilization (IVF), assisted conception, endometriosis and pelvic pain, tubal microsurgery and advanced laser laparoscopy.

At UCSD School of Medicine, Dr. Brody is a member of the clinical faculty in the Division of Endocrinology & Metabolism. He is a Staff Physician at Scripps Memorial Hospital in La Jolla, Sharp Memorial Hospital and Grossmont Hospital. At Alvarado Hospital Medical Center, he is the Medical Director of Reproductive Endocrinology.  

As a distinguished clinician, Dr. Brody has been designated Fellow of the American College of Obstetricians & Gynecologists, Fellow of the American College of Physicians, Fellow of the International College of Surgeons, and Fellow of the American College of Clinical Endocrinologists. He served in the uniformed services as a Lieutenant Commander (surgeon) in the U.S. Public Health Service, and was stationed at the National Institutes of Health in Bethesda, Maryland from 1980 to 1983.

Proceptin is the first physician-formulated preparation. It has been formulated to provide many of the nutrients which have been shown to support successful male reproductive function. It has been developed as a result of over 60 research studies addressing the role of antioxidants, and amino acid precursors in male reproductive function.

Proceptin is the only product of its kind containing the potent antioxidant Pycnogenol. Pycnogenol as well has been proven to improve parameters on semen analysis. Additionally it contains high doses of carnitine, CoQ-10, selenium & zinc, vitamins C, E, and B complex. Proceptin is recommend for men, when couples are trying to have a baby.

Proceptin is a nutritional supplement and treatment that does not contain any herbs or preservatives. Each component in Proceptin has been verfiied in clinical studies published in leading medical journals.

Information on Infertility in Men

In the past it was considered necessary to address the reproductive function of a man only if his sperm count was found to be low. However, It is now known that count is not the only factor in impaired fertility cases, motility and morphology also play a major role in a man’s ability to fertilize.

A man with fewer than 5 million sperm per milliliter of semen is often infertile. A sperm count below 20 million is considered low. In these cases the men might be sub-fertile or infertile. However, it should be understood that a man can be sub-fertile even if he has a normal sperm count of between 20 and 250 million sperm per milliliter of semen.
The sperm’s ability to move is referred to as motility. The most successful sperm are those that are able to move forwards rapidly. Rapid motion forward is defined as a sperm that is able to travel at least half its length in one second. Often times, sperm are found to lack this essential aspect of motility and they end up swimming slowly or in the wrong direction, some even swim in circles. The sperm’s ability to move correctly is directly linked to its shape.

The morphology of sperm is the third key factor in evaluating the role of abnormal sperm cells. A normal sperm is made up of a head, a mid piece and a tail. A normal head is oval in shape and can be easily distinguished from the mid piece. The mid piece should have approximately half to three quarters the area of the head. And the tail should be around four or five times the combined length of the head and mid piece. When variation in just one of these areas occurs, a sperm’s chance for success is greatly reduced as a miss-shapen head or a deformed tail can cause the sperm to be a weak swimmer or to be incapable of maintaining a straight path.

If you are a man who is looking for a male infertility treatment and seriously considering having children visit the www.Proceptin.com website for more information on at www.Proceptin.com

For more information or to order the Proceptin male infertility treament visit www.Proceptin.com

Proceptin - A supplement to increase male fertility www.Proceptin.com Phone: 858-635-1278

# # #

Steven A. Brody, M.D., Ph.D. received his Bachelor's degree and Master's degree from Brown University in Providence, RI. He received his medical degree from Washington University School of Medicine in St. Louis. He completed his internship at Yale University School of Medicine in New Haven, Connecticut. In 1986 he completed his OB/GYN Residency at Stanford University Medical Center. After finishing his Fellowship in Reproductive Endocrinology at Baylor College of Medicine, he joined the full-time medical faculty as Associate Director of the Division of Reproductive Endocrinology until 1992.

Dr. Brody is Board Certified in Obstetrics & Gynecology, Internal Medicine, Endocrinology & Medicine, and the subspecialty of Reproductive Endocrinology & Infertility.

For more information on Dr. Brody and the Proceptin male infertility treatment visit www.proceptin.com